Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
NCT02906852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264
Last updated 2019-05-16
Summary
The aim of this study is to evaluate the performance of Inivata liquid biopsy analysis compared with standard tissue biopsy analysis for detection of genomic alterations in patients with advanced lung cancer.
Conditions
Sponsors & Collaborators
-
Vector Oncology
collaborator OTHER -
Inivata
lead INDUSTRY
Principal Investigators
-
Ramaswamy Govindan, MD · Washington University School of Medicine
-
Edward Kim, MD · Atrium Health Levine Cancer Institute
-
Clive Morris, MD · Inivata
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-01
- Primary Completion
- 2018-05-31
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites
NCT04474613 ·Status: TERMINATED ·Phase: NA
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Liquid Biopsy for Detection of Driver Mutation in NSCLC
NCT02778854 ·Status: UNKNOWN
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
NCT04566432 ·Status: RECRUITING
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
NCT00607425 ·Status: TERMINATED
-
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
NCT00923884 ·Status: COMPLETED
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NCT05384769 ·Status: RECRUITING ·Phase: NA
-
Testing the Engaged Approach to Lung Cancer Screening
NCT06327074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer
NCT02762877 ·Status: TERMINATED
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
NCT00897364 ·Status: COMPLETED
-
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)
NCT06228508 ·Status: NOT_YET_RECRUITING
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors
NCT05921474 ·Status: UNKNOWN
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED
-
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807 ·Status: RECRUITING ·Phase: NA
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING